Kymera Therapeutics, Inc. (KYMR) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.45M | -88.7% |
| 2024 | $12.84M | -62.8% |
| 2023 | $34.48M | +1115.8% |
| 2022 | $2.84M | +77.6% |
| 2021 | $1.60M | -82.4% |
| 2020 | $9.10M | +1609.8% |
| 2019 | $532.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.45M | -88.7% |
| 2024 | $12.84M | -62.8% |
| 2023 | $34.48M | +1115.8% |
| 2022 | $2.84M | +77.6% |
| 2021 | $1.60M | -82.4% |
| 2020 | $9.10M | +1609.8% |
| 2019 | $532.0K | — |